Medication tested to help stop binge eating and support weight loss
NCT ID NCT03926052
Summary
This Yale University study tested whether a medication called lisdexamfetamine (LDX) could help people with binge-eating disorder and obesity maintain their progress after initial treatment. The Phase 3 trial involved 61 adults who had already responded well to earlier therapy. Researchers compared LDX against a placebo to see which was better at preventing binge-eating relapse and supporting weight management over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yale Department of Psychiatry
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.